3 Value Stocks to Buy at 52-Week Low in February

05:44pm, Wednesday, 07'th Feb 2024
In the face of persistent market challenges, savvy investors focus on value stocks. Despite the headwinds of political uncertainty, inflationary pressures and the Federal Reserve's looming decisions,
It's tough to make the argument that stocks are cheap. But it's still possible to find some value.
Can Pfizer's stock bounce back? Pfizer's revenue crashed last quarter and it posted a massive $3.4 billion net loss. Problem is that many of the company's top products are generating little or no grow

3 Biotech Stocks to Buy on the Dip: February 2024

07:35am, Wednesday, 07'th Feb 2024
Biotech investing is not for impatient investors. So why is it attractive to some investors?

Pfizer: The 6.3% Yield Is A Appealing

07:15am, Wednesday, 07'th Feb 2024
Pfizer reported better than expected Q4 earnings, with solid organic top line growth in FY 2023, despite a drop in COVID-19 product revenues. The drop-off in COVID-19 product sales has caused negative

7 Retirement Stocks to Buy at 52-Week Lows

08:53pm, Tuesday, 06'th Feb 2024
Investors are pricing in a substantial number of interest rate cuts in the coming months, which has led to a surge in stock prices. And while investors might think they've missed out on the run, they
At recent prices, shares of AT&T offer a 6.2% yield that's backed by its steadily growing telecom business. Pfizer shares have been beaten down so low that they offer a 6.2% dividend yield.
Within the vast landscape of publicly listed companies across the U.S. stock exchanges, sleeper stocks are perhaps the most intriguing. These stocks usually dwell in the shadows due to near-term headw
While it's a relative rarity because price generally discounts everything, that doesn't mean you can't find stocks to buy on dip. With thousands upon thousands of securities available, it's impossible
Pfizer (PFE) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Better Dividend Stock: Pfizer vs. AbbVie

08:54am, Monday, 05'th Feb 2024
Both Pfizer and AbbVie have been raising their dividend payments every year for more than a decade. Pfizer offers a higher dividend yield than AbbVie but it's growing at a slower pace.
Pfizer's post-COVID hangover has created a temporary soft spot in its longer-term stock trajectory. Confluent's growth remains solid, even as its stock price has suffered.
High dividend yields are not the same as good dividend stocks to buy. Medical Properties Trust has a nest of problems, and little leeway to solve them.

Pfizer: Simply Too Cheap To Ignore

07:00am, Sunday, 04'th Feb 2024
Pfizer reported a record $100 billion in annual revenue in 2022 due to the development of Comirnaty and Paxlovid. COVID treatments no longer boost sales, causing the stock to trade near a ten-year low

3 Fabulous Dividend Stocks to Buy in February

05:50am, Sunday, 04'th Feb 2024
AbbVie is a Dividend King with plenty of growth potential left. Novartis offers investors a high dividend yield and strong prospects.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE